Tumor Mutational Burden Analysis

  • 1.00 Dollar US$
  • Published date: July 8, 2020
    • New York, New York, United States

CD Genomics provides both product and service for rapid measurement of TMB. We employ Illumina sequencing platform to obtain the genetic variations information in a more efficient way. https://www.cd-genomics.com/diseasepanel/tumor-mutational-burden-analysis.html

Result 0 votes
CD Genomics
0 votes

Useful information

  • Avoid scams by acting locally or paying with PayPal
  • Never pay with Western Union, Moneygram or other anonymous payment services
  • Don't buy or sell outside of your country. Don't accept cashier cheques from outside your country
  • This site is never involved in any transaction, and does not handle payments, shipping, guarantee transactions, provide escrow services, or offer "buyer protection" or "seller certification"

Related listings

  • Human PTH2R/Galpha15 Stable Cell Line-Chem-1

    Human PTH2R/Galpha15 Stable Cell Line-Chem-1

    Cell Biology & Microbiology New York (New York) July 8, 2020 1.00 Dollar US$

    Catalog #: ACC-RG0749 Gene Name PTH2R Abbr Chem-1-HuPTH2R/Galpha15 Alias PTH2R,PTHR2 Growth Properties Adherent Host Cell Chem-1 https://www.creative-bioarray.com/acroscell/human-pth2r-galpha15-stable-cell-line-chem-1-acc-rg0749-item-540.htm

  • Anti-GD2 Antibody-Cytokine Fusion Protein, scFv-Fc (14.18)-IL2

    Anti-GD2 Antibody-Cytokine Fusion Protein, scFv-Fc (14.18)-IL2

    Cell Biology & Microbiology Shirley (New York) June 29, 2020 1.00 Dollar US$

    This antibody-cytokine fusion protein was achieved by conjugating/fusing the Anti-GD2 scFv-Fc to IL2. It was expressed in CHO and purified with affinity chromatography. The immunocytokine retains the ability to bind the GD2 as well as the biological ...

  • Human anti-OVA (aa324-337) T cell receptor, pCDTCR1

    Human anti-OVA (aa324-337) T cell receptor, pCDTCR1

    Cell Biology & Microbiology Shirley (New York) January 31, 2020 1.00 Dollar US$

    The vector of anti-OVA T cell receptor (TCR) is constructed for the engineering of T cell to target OVA. The T cells are genetically modified through transduction with a retroviral vector expressing OVA-specific T cell receptor. And the vector produc...